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tardiovascular diseases (CVDs) and diabetes
are major public health problems worldwide.
They accounted for 32% of the total deaths
lobally and contributed to 11% of the global burden
f disability adjusted life years (DALYs) in the year
005 (1). The fast-changing demographic profile in
he developing world has resulted in the emergence of
ardiovascular disease and diabetes as major contribu-
ors to disease burden, leading to substantial increases
n economic and health care costs.
Developing countries comprising low-income
ountries (LIC) and low-middle-income countries
LMIC), because of their larger population, account
or a substantially greater DALY loss as compared
ith developed countries (2,3). The Global Burden of
isease Study projects a 55% increase in DALY loss
ttributable to CVD between 1990 and 2020 in de-
eloping countries (4). In contrast, developed nations
ill witness a 14.3% reduction in the proportion of
ALY loss attributable to CVD during the same pe-
iod. Thus, the increasing burden of CVD would be
orne mostly by the developing countries in the next
decades. To address this increasing challenge, these
ountries need to develop effective national policies,
trategies, and programs aimed at the prevention of
VDs. For this to be achieved, evidence needs to be
enerated from locally conducted research. Applied
esearch is also needed to support evidence-based
ractice, to develop context specific guidelines, and to
nderstand the complex dynamics of the CVD epi-
emic in these country settings. It has been demon-
trated that research translates to better technologies
nd diagnostic methods, improved application of
ost-effective interventions, more informed health
are users, and the promotion of healthy lifestyles.
owever, the commitment of various governments tonvest in building research capacity varies greatly. In h990, the Commission on Health Research for Devel-
pment (CHRD) estimated that 10% of the global
ealth research resources (totaling U.S. $30 billion/
ear in 1986) were accessed by the developing coun-
ries, which accounted for 90% of the world’s
ealth problems (5). Despite an increase in the global
ealth research expenditure to U.S. $55.8 billion by
996, the “10/90 gap” has persisted (6). Similar pat-
erns were observed when the Global Forum for
ealth Research compared research and development
uring the years 2001 and 2003 (7). This study dem-
nstrated a U.S. $20 billion increase in research and
evelopment for health expenditures within 2 years.
owever, the spending among high-income countries
ccounted for most of the increase globally (7). On
he other hand, in developing countries, allocation to
he health sector is low and to health research specifi-
ally is almost negligible (7). In 2001, an assessment
f global resources for health research noted that none
f the developing countries studied had met the 1990
HRD recommendation to spend as much as 2% of
he national health budget on health research: only
ndia, Brazil, and Cuba had spent notably closer to
he target of 1% to 2% (8). Likewise, most countries
all short of the recommended allocation of 5% of
heir health development budget for health research
nd research capacity building (5). Such inadequate
nvestments could potentially translate to low research
apacity, poor-quality research, and low research out-
uts, especially in CVD research, in developing coun-
ries, which are additionally burdened by pre-transi-
ional diseases such as communicable disease and
ndernutrition.
Research publications in peer-reviewed journals, al-
hough not the best indicator, give a reasonable indica-
ion of the type and impact of research conducted by
ealth professionals. Quantification and comparison of
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December 11, 2007:2322–8 From Around the Worldesearch publications from developed and developing coun-
ries would be potentially useful to funding agencies and
overnments in informed policy-making for addressing
nequalities in health, setting priorities, health resource allo-
ation, and financing health research. However, data on the
ature of research publications are limited both from devel-
ped and developing countries. Mendis et al. (9) attempted
o quantify the CVD research output from different catego-
ies of nations. They searched the MEDLINE database and
eported that developed market economies contribute 78%
f the research publications, highlighting the research gaps
n the developing nations. Earlier studies on the geography
f biomedical publications in general (10), and of mental
ealth (11) and HIV/AIDS-associated publications (12)
ave also reported similar findings. Even within developed
ountry settings, differentials exist in CVD research out-
uts. De Jong et al. (13) showed that the U.S. leads re-
earch in clinical cardiology among G-7 nations. Further,
n most G-7 nations, the quality and quantity of cardiologi-
al publications lag behind those of the smaller Western
uropean countries (13).
However, all of these studies did not attempt to identify
he type of research publications in the field of cardiovascu-
ar diseases. Specific areas of research that would be impor-
ant for policy-makers and funding agencies are research
ddressing issues of equity, such as health systems, cost-
ffectiveness, and quality of life. To quantify the amount of
esearch and to delineate the type of research in CVD, we
ndertook a review on CVD research-related publications
mong several countries belonging to the various income
roups as defined by the World Bank (14). We also sought
o compare the proportion of CVD research related to
ealth system, quality of care, costing/cost-effectiveness
mong selected developed, and developing countries.
We used the World Bank classification of countries into
igh-income (HIC), high-middle-income (HMIC), LMIC,
nd LIC based on their gross national product estimates of
004 (14). A total of 90 countries were selected for the
tudy. We initially selected the top 21 countries from each
f the 4 income groups. To include large/most populous
ountries, we also included 6 large countries that did not
eature in the original selection. These countries were Rus-
ia, South Africa, Argentina, Egypt, Indonesia, and Bang-
adesh. The complete list of countries is given in Table 1.
Our initial search strategy was to identify the most sensi-
ive database yielding the maximum number of search re- cults with appropriate key words. We made multiple
earches using different key words, such as “cardiovascular”,
heart”, “coronary”, “heart failure ”, “rheumatic”, “disease”,
nd “country name” in MEDLINE, PubMed, and EMBASE
or randomly selected countries from the aforementioned list.
e found that, for any particular country, PubMed retrieved
he maximum number of publications with the aforemen-
ioned search terms. We therefore used the PubMed database
or the purpose of this study.
A PubMed search was performed for all 90 countries using
he previously mentioned key words. The search was limited
o publications from human studies, in all languages, for the
ears 1994, 1995, 2004, and 2005. We chose these years to
valuate changes in trend of publications among the selected
ountries. We excluded publications not related to CVDs or
iabetes. The details of the search strategy are provided in the
chematic diagram (Fig. 1).
ountry Group-Wise
istribution of CVD Publications
uring the reference period of 4 years (1994, 1995, 2004,
nd 2005), a total of 253,681 articles were published from
0 countries. In the initial search we obtained 17,531 arti-
les pertaining to CVD. Of these 17,531 published articles,
e excluded 1,321 articles as they were not related to
VD. Of the remaining 16,210 (6.4% of the total) articles,
,823 were original publications and the remaining were
ncillary publications (see Fig. 1 for the classification). The
.S. had the greatest number of CVD-related publications
6,161), whereas 10 countries (5 from LIC) had no such
ublications during this period. The majority of the CVD-
elated publications were from HIC (n  13,354; 82.4%).
ontributions from other country groups were consider-
bly small, that is, HMIC (n  1,145; 7.1%), LMIC (n 
,077; 6.6%), and LIC (n  634; 3.9%). The details are
hown in Figure 2. Of the original publications, most (n 
,107; 72.3%) were observational studies. Further, two-
fths of the observational studies were either case reports/
ase series (n  2,940; 41.3%). The next largest group of
ublications were randomized control trials (n  1,519;
5.5%) followed by basic science research and genetic stud-
es (n  618; 6.3%). The publications related to health
ystem, quality of care, cost, and cost-effectiveness ac-
ounted for a minuscule 5.9% (n  579) of original publi-
ations.
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From Around the World December 11, 2007:2322–8rofile of Original
ublications by Country Groups
he profile of the original publications is shown in Figure 3.
n brief, when analyzed country wise, the observational
tudies formed the major publication group among the 4
ountry groups: HIC (n  5,550; 71.1%), HMIC (n 
37; 78.4%), LMIC (n  592; 73.5%) and LIC (n  328;
2.0%). Proportion of publications from clinical trials
anged from 10% to 17%, with the lowest number (n 
9; 10.0%) from LIC. The proportion of publications from
asic science and genetics research formed 13.2% in LMIC,
.2% in HMIC, 5.4% in HIC, and 3.3% in LIC. The larg-
st proportion of publications related to health system,
uality of care, and cost/cost-effectiveness was observed
rom HIC (n  543, 94% of publications in this category).
he HMIC and LMIC contributed to a smaller proportion
3% each) in this category. None of the LIC had any publi-
Table 1 List of Countries From Different Income Groups
HIC HMIC
GNI
Ranking Country
GNI
Ranking Country
1 Luxembourg 56 Antigua & Barbuda
2 Norway 57 Barbados
3 Bermuda 58 Czech Republic
4 Switzerland 59 Trinidad and Tobago
5 US 60 Oman
6 Denmark 61 Hungary
7 Liechtenstein 62 Seychelles
8 Iceland 63 St. Kitts and Nevis
9 Japan 64 Estonia
10 Sweden 65 Palau
11 Channel Island 66 Mexico
12 Ireland 67 Croatia
13 United Kingdom 68 Slovak Republic
14 Finland 69 Poland
15 Austria 70 Lithuania
16 Netherlands 71 Latvia
17 Belgium 72 Lebanon
18 Germany 73 Chile
19 France 74 Costa Rica
20 San Marino 75 Malaysia
21 Canada 76 Mauritius
91 Argentina
94 South Africa
95 Russian Federation
NI  gross national income; HIC  high-income countries; HMIC  high-middle-income counation conforming to this category. vhange in the Number and
attern of Publications Over a Decade
e compared the number of publications in the years 1994
o 1995 with the years 2004 to 2005. We observed a 130%
ncrease in the number of publications related to CVD
4,912 vs. 11,298); this increase was observed across all of
he country groups. Despite this increase, we did not ob-
erve any change in the ratio of publications between the
igh-income (HIC and HMIC) and low-income (LMIC
nd LIC) groups of countries (8.6 in 1994 to 1995 vs. 8.4
n 2004 to 2005; p  0.64). Furthermore, the proportion
f the subcategories of publications remained similar be-
ween the 2-year groups under comparison.
uality of Publications
o assess the quality of the published studies, we randomly
hose 250 CVD publications from each country group and
ssessed their impact factor by obtaining the impact factor
LMIC LIC
NI
nking Country
GNI
Ranking Country
96 Brazil 150 Cameroon
97 Romania 151 Nicaragua
98 Jamaica 152 Congo, Republic
99 Bulgaria 153 Côte d’Ivoire
00 Fiji 154 Bhutan
01 Tunisia 155 Lesotho
02 Serbia and Montenegro 156 Moldova
03 Thailand 157 Senegal
04 Maldives 158 India
05 Marshall Islands 159 Pakistan
06 Namibia 160 Mongolia
07 Peru 161 Papua New Guinea
08 El Salvador 162 Yemen, Republic
09 Macedonia FYR 163 Solomon Islands
10 Iran 164 Timore-Leste
11 Algeria 165 Vietnam
12 Kazakhstan 166 Benin
13 Surinam 167 Comoros
14 Ecuador 168 Sudan
15 Jordan 169 Guinea
16 China 170 Kenya
31 Egypt Arab Republic 175 Bangladesh
38 Indonesia
MIC  low-middle-income countries; LIC  low-income countries.G
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December 11, 2007:2322–8 From Around the Worldrticles (250 from each of the country groups), 50% (n
479; 49.7%) were published in journals with a listed
mpact factor at bioscience.org. When disaggregated into
orld Bank country groups, HIC had the highest publica-
ion in a journal with a listed impact factor (n  148;
0%) followed by HMIC (n  118; 47%) and LMIC (n
16; 46%), and LIC had the least publication in journals
ith impact factor (n  97; 39%). This trend was statisti-
ally significant (p  0.001). The mean impact factor of
ublications was again greater in HIC (2.96) followed by
MIC (2.35), HMIC (2.01), and LIC (1.87).
ublications in Relation to the Population
e compared the number of publication from each of the
ountry groups with their relative population size. We used
he mid-2005 population for the population size (16) and
ound that HIC (which accounts for 14.6% of the population
Figure 1 Search Strategy and Classification of Publications
CVD  cardiovascular disease.f these 90 countries) had the greatest number of publications Ler hundred thousand population (27.3/100,000). Similarly,
he number of CVD-related publications per hundred thou-
and population (1.83/100,000) was also greatest among this
roup. We also found that HMIC, accounting for 9.3% of the
otal population from the 90 selected countries, had 7.2% and
.1% of total and CVD publications, respectively. This num-
er translated into 0.25/100,000 CVD-related publications
er population in the HMIC. The LMIC and LIC groups,
hich together account for 76% of the population, had just
4.3% of total publications and 10.5% of CVD publications.
n addition, LIC had the least number of CVD-related publi-
ations per hundred thousand population (0.04/100,000),
hereas LMIC had a slightly greater number of publications
er hundred thousand populations (0.05/100,000). Publica-
ions on health system, quality of care, and cost/cost-
ffectiveness related to CVD were substantially low among
MIC (0.001/100,000 population), and publications in this
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From Around the World December 11, 2007:2322–8ategory were nonexistent in LIC. The corresponding figures
or HIC and HMIC were 0.074/100,000 and 0.004/100,000,
espectively. The details are presented in Table 2.
Figure 2 Cardiovascular Disease
Publications According to Country Groups
HIC  high-income countries; HMIC  high-middle-income countries;
LIC  low-income countries; LMIC  low-middle-income countries.
Figure 3 Profile of Original Publications by Country Groups
Cost  studies on costing and cost-effectiveness; HS  studies related to hea
cross sectional studies, case control studies and cohort studies); QLY  studi
& Gene  basic science and genetic studies; other abbreviations as in Figure 1ublications and Health Expenditure Indicators
o ascertain the relationship of government spending and
ealth research output, we matched the total number of
VD-related publications against the expenditure on
ealth in that country. As indicators of health expenditure,
e used both the total expenditure on health as a percent-
ge of GDP and the per capita government expenditure in
ealth at international dollar rates, which are available from
he website of World Health Organization (17). For this
omparison, the countries were grouped into 2 (above and
elow the mean health expenditure indicators) and were
nalyzed using a t test with the SPSS software package (ver-
ion 11.5, SPSS Inc., Chicago, Illinois).
Health expenditure indicators were available for 78 coun-
ries. To evaluate the relationship of health expenditure and
ublications, we categorized these countries into 2 groups
ccording to their total spending on health care as a percentage
f gross domestic product (GDP), that is, countries spending
ore or less than 6.7% of their GDP (which was the mean
alue for these 78 countries). Countries spending more than
.7% of their GDP toward health had significantly greater
umber of CVD-related publications (p 0.042) as com-
tem; Observational  observational studies (i.e., case series/case reports,
ted to quality of care; RCT  studies related to randomized control trials; Scilth sys
es rela
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December 11, 2007:2322–8 From Around the Worldared with those with lower allocation levels. A similar com-
arison was made between country groups categorized accord-
ng to the per capita government expenditure (at international
ollar rate) on health care. Countries with more than $729 as
er capita government expenditure (mean value for 78 coun-
ries) on health had a significantly greater number (p 0.001)
f CVD publications.
hat Are the Reasons for the
nsufficient Research From LIC and LMIC?
otential reasons for such insufficient research activity
ould be several but speculative. First, limited funding for
ealth care has a cascading effect on health research, specifi-
ally in basic and epidemiological research, which is re-
ource intensive. Again, resulting from a lack of resources,
esearch outputs from clinicians in countries with poor
esearch support are likely to be restricted to case reports
nd case series. Such trends are particularly evident from
he LMIC and LIC publications. Second, non–English-
peaking countries tend to have lower research output in
he highest-ranking general medical journals. Man et al.
18) reported that Asian countries had generally low rates
f publication in the five highest-ranked general medical
ournals when compared with English-speaking nations and
ertain northern European countries such as Denmark, the
etherlands, Switzerland, and Sweden (18). Third, govern-
ents and policy-makers in LIC and LMIC believe that
oncommunicable diseases are not a major problem and
onsequently apportion lower resources for research in this
rea. In an earlier study conducted by our group in 3 devel-
ping countries, policy-makers did not perceive CVD as a
ajor problem and considered pre-transitional communi-
able disease and nutritional diseases to be greater threats
mong the population (19). Such beliefs could potentially
Table 2 Publications in Relation to Population
Publica
Country Groups
Population
(n  100,000) (%) Total
HIC 7,315 (14.6) 199,326 (78.6) 13,3
HMIC 4,666 (9.3) 18,153 (7.2) 1,1
LMIC 20,781 (41.5) 20,540 (8.1) 1,0
LIC 17,366 (34.6) 15,662 (6.2) 6
Total 50,127 (100.0) 253,681 (100.0) 16,2
ost  studies on costing and cost-effectiveness; CVD  cardiovascular diseases; HS  studienfluence health research funding patterns and the resource pow in the health sector. Identifying financial flow in
ealth research is the key to mapping various constraints in
VD health research. Hence, it would be appropriate to
arry out in-depth analysis of the funding pattern for CVD
esearch in developing countries using appropriate method-
logies such as the Health Research Financial Flow Matrix
eveloped by the Global Health Research Forum (20).
mplications for
overnments and Policy-Makers
his study highlights the differences in the publications
elated to CVD among countries of the world. Studies on
ealth system, cost/cost-effectiveness, and quality of care
ormed a small proportion of publications overall and were
inuscule or absent among LIC and LMIC. We found
hat the number of publications per 100,000 population
as almost 37 times greater in HIC as compared to that of
IC and LMIC.
Despite the 15-year gap, our results almost mirror the
ndings of the CHRD conducted in 1990. The CHRD
nding of a significant “10/90” gap in health and health
esearch between developed and developing countries re-
arkably did not change even after 10 years. Although
0% of CVDs occur in LIC and LMIC, even now, the
esearch output from these countries is just around one-
enth of global research output on CVD. Therefore, there
s an urgent need to alter this pattern and evaluate methods
or channelizing resources for health research to the need-
er, LIC and LMIC where there is a definite upsurge in
hronic diseases, affecting increasingly younger population
roups. Given the low priority afforded to research related
o altering health systems and evaluating cost-effectiveness
nd quality of care related to CVD, especially in the LIC
nd LMIC, governments and funding agencies need to
n (%) Publications per 100,000 Population
d HS/QLY/Cost Total
CVD
Related HS/QLY/Cost
.4) 543 (93.8) 27.3 1.83 0.074
1) 20 (3.5) 3.9 0.25 0.004
6) 16 (2.8) 1.0 0.05 0.001
9) 0 (0.0) 0.9 0.04 0
0.0) 579 (100.0) 5.1 0.32 0.012
d to health system; QLY  studies related to quality of care; other abbreviations as in Table 1.tions,
CVD
Relate
54 (82
45 (7.
77 (6.
34 (3.
10 (10rioritize this area of research funding.
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From Around the World December 11, 2007:2322–8tudy Limitations
n this study, not all databases have been included, but are
onfined to the PubMed database and articles published in
ournals indexed in PubMed alone, limited to a period of 2
ears. This may underestimate the proportion of publica-
ions from developing nations, as many of their journals
ay not be indexed in PubMed. However, the validity of
ur results is suggested by another publication that also
btained a nearly similar proportion of CVD publications
n the years 1996 to 2001 using the Scientific Citation In-
ex (21). We also did not account for gray literature in this
tudy, which could be another source for underestimation
f research publications among LMIC and LIC, because
ost researchers from these countries may be publishing in
ocal journals that may not be indexed. We did not evaluate
he funding sources, the flow, and pattern of funding in
his study. These issues need to be addressed in a separate
tudy focusing on mapping of research flow and funding
atterns in a few selected countries.
onclusions
he research output (measured through PubMed citations)
s low among LIC and LMIC. Specifically, research publi-
ations that could influence policy are virtually nonexistent
n LIC and LMIC. On quality parameters, as assessed by
he mean impact factor of publications, LIC and LMIC,
lthough having lesser impact factor levels, did not fare
orse, as compared with the quantity parameters. A major
eason for the lower output may be the low government
pending among LIC and LMIC.
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